2. Academic Validation
  3. Ergosterol alleviates hepatic steatosis and insulin resistance via promoting fatty acid β-oxidation by activating mitochondrial ACSL1

Ergosterol alleviates hepatic steatosis and insulin resistance via promoting fatty acid β-oxidation by activating mitochondrial ACSL1

  • Cell Rep. 2025 Jan 28;44(1):115203. doi: 10.1016/j.celrep.2024.115203.
Zu-Guo Zheng 1,  Yi-Ping Zhang 2,  Xiao-Yu Zhang 2,  Meng-Yao Qin 3,  Yin-Yue Xu 2,  He Wu 2,  Run-Qing Liu 2,  Qiu-Yi Wu 2,  Ming-Su Wang 2,  Chong Zhang 2,  Yue-Qin Zheng 2,  Jian-Ye Dai 4,  Ping Li 5,  Hua Yang 6
Affiliations

Affiliations

  • 1 State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China. Electronic address: zuguozheng@cpu.edu.cn.
  • 2 State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
  • 3 Collaborative Innovation Center for Northwestern Chinese Medicine & School of Pharmacy, Lanzhou University, Lanzhou, Gansu, China.
  • 4 Collaborative Innovation Center for Northwestern Chinese Medicine & School of Pharmacy, Lanzhou University, Lanzhou, Gansu, China. Electronic address: daijy@lzu.edu.cn.
  • 5 State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China. Electronic address: liping2004@126.com.
  • 6 State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China. Electronic address: yanghuacpu@126.com.
PMID: 39799570 DOI: 10.1016/j.celrep.2024.115203
Abstract

Sterols target sterol-sensing domain (SSD) proteins to lower Cholesterol and circulating and hepatic triglyceride levels, but the mechanism remains unclear. In this study, we identify acyl-coenzyme A (CoA) synthetase long-chain family member 1 (ACSL1) as a direct target of ergosterol (ES). The C-terminal domain of ACSL1 undergoes conformational changes from closed to open, and ES may target the drug-binding pocket in the acetyl-CoA synthetase-like domain 1 (ASLD1) of ACSL1 to stabilize the closed conformation and maintain its activity. Moreover, ES is mainly enriched in the mitochondria and promotes fatty acid β-oxidation through ACSL1 allosteric activation. Structure-activity relationship analysis reveals how different structural sterols interact with the sterol-sensing domain-containing protein (SCAP) and ACSL1, explaining their regulatory effects on lipid metabolism. Moreover, our findings reveal that the combination of SCAP inhibitor 25-hydroxycholesterol (25-HC) and ES has a stronger lipid-lowering effect than alone.

Keywords

ACSL1; CP: Metabolism; SCAP/SREBP; ergosterol; hepatic steatosis; insulin resistance.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z